Tisolagiline

Overview of the drug Tisolagiline

Tisolagiline
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Tisolagiline, also known by its developmental code name TV-3326, is a selective monoamine oxidase B inhibitor (MAO-B inhibitor) that has been investigated for its potential use in the treatment of neurodegenerative disorders, such as Parkinson's disease and Alzheimer's disease.

Pharmacology

Tisolagiline functions primarily as a selective inhibitor of the enzyme monoamine oxidase B (MAO-B). This enzyme is responsible for the breakdown of dopamine in the brain, and its inhibition leads to increased levels of dopamine. This mechanism is particularly beneficial in the treatment of Parkinson's disease, where dopamine levels are pathologically low.

Unlike non-selective monoamine oxidase inhibitors (MAOIs), selective MAO-B inhibitors like Tisolagiline do not require dietary restrictions to avoid tyramine-induced hypertensive crisis, making them safer and more convenient for patients.

Potential Therapeutic Uses

Tisolagiline has been studied for its potential benefits in several neurodegenerative conditions:

Parkinson's Disease

In Parkinson's disease, the progressive loss of dopaminergic neurons leads to motor symptoms such as tremor, rigidity, and bradykinesia. By inhibiting MAO-B, Tisolagiline may help to alleviate these symptoms by increasing the availability of dopamine in the brain.

Alzheimer's Disease

Research has also explored the use of Tisolagiline in Alzheimer's disease, where it may exert neuroprotective effects. The exact mechanism by which MAO-B inhibitors could benefit Alzheimer's patients is not fully understood, but it is hypothesized that they may reduce oxidative stress and neuronal damage.

Development and Research

Tisolagiline was developed by Teva Pharmaceutical Industries and has undergone various stages of clinical trials. However, as of the latest updates, it has not been approved for clinical use. The research into Tisolagiline highlights the ongoing efforts to find effective treatments for neurodegenerative diseases, which remain a significant challenge in modern medicine.

Chemical Properties

Tisolagiline is a small molecule with the chemical formula C₁₃H₁₇NO. Its structure includes an indanamine moiety, which is crucial for its activity as an MAO-B inhibitor.

Chemical structure of Tisolagiline

Related pages

• Monoamine oxidase inhibitor
• Parkinson's disease
• Alzheimer's disease
• Dopamine